[A12-01] Extract from Cannabis sativa L. - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 02.04.2012
Project no.:
A12-01
Commission:
Commission awarded on 02.01.2012 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Head and nerves, Muscles, bones and joints
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Project no. | Title | Status |
---|---|---|
A18-27 | Extract from Cannabis sativa (spasticity due to multiple sclerosis) - Benefit assessment according to §35a Social Code Book V (expiry of the decision) | Commission completed |
A11-12 | Extract from Cannabis sativa L. - Consultation on content and completeness of the dossier | Commission completed |
Federal Joint Committee (G-BA)
2012-06-21 A G-BA decision was published.